Difference between revisions of "Adenosquamous carcinoma of the lung"
Jump to navigation
Jump to search
Line 45: | Line 45: | ||
===Images=== | ===Images=== | ||
www | <gallery> | ||
Image: Adenosquamous carcinoma of lung -- intermed mag.jpg | ASC with SC - intermed. mag. (WC) | |||
Image: Adenosquamous carcinoma of lung - alt -- intermed mag.jpg | ASC with SC - intermed. mag. (WC) | |||
Image: Adenosquamous carcinoma of lung -- high mag.jpg | ASC with SC - high mag. (WC) | |||
Image: Adenosquamous carcinoma of lung -- very high mag.jpg | ASC with SC - very high mag. (WC) | |||
</gallery> | |||
====www==== | |||
*[http://www.webpathology.com/image.asp?case=415&n=21 Lung adenosquamous carcinoma (webpathology.com)]. | *[http://www.webpathology.com/image.asp?case=415&n=21 Lung adenosquamous carcinoma (webpathology.com)]. | ||
*[https://www.flickr.com/photos/pulmonary_pathology/7491350926/ Lung adenosquamous carcinoma (flickr.com/Yale Rosen)]. | *[https://www.flickr.com/photos/pulmonary_pathology/7491350926/ Lung adenosquamous carcinoma (flickr.com/Yale Rosen)]. |
Revision as of 05:34, 29 December 2015
Adenosquamous carcinoma of the lung | |
---|---|
Diagnosis in short | |
Adenosquamous carcinoma of lung. H&E stain. | |
LM DDx | squamous cell carcinoma of the lung, adenocarcinoma of the lung |
Site | lung - see lung tumours |
| |
Prevalence | rare |
Clin. DDx | other lung tumours |
Adenosquamous carcinoma of the lung, also lung adenosquamous carcinoma, is a rare epithelial derived malignancy of the lung with features of both adenocarcinoma and squamous cell carcinoma.
It is grouped with the non-small cell lung cancers.
General
- Rare.
- Respond to tyrosine kinase inhibitors.[1][2]
Microscopic
Features:
- Adenocarcinoma component.
- Squamous cell carcinoma component.
Images
www
- Lung adenosquamous carcinoma (webpathology.com).
- Lung adenosquamous carcinoma (flickr.com/Yale Rosen).
See also
References
- ↑ Song, Z.; Lin, B.; Shao, L.; Zhang, Y. (Sep 2013). "Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma.". J Chin Med Assoc 76 (9): 481-5. doi:10.1016/j.jcma.2013.05.007. PMID 23769878.
- ↑ Iwanaga, K.; Sueoka-Aragane, N.; Nakamura, T.; Mori, D.; Kimura, S. (2012). "The long-term survival of a patient with adenosquamous lung carcinoma harboring EGFR-activating mutations who was treated with gefitinib.". Intern Med 51 (19): 2771-4. PMID 23037472.